Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-27

Clinical Trial Update: Inhaled Ciclesonide Study in Preterm Infants [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating inhaled ciclesonide for bronchopulmonary dysplasia in preterm infants is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alvesco (ciclesonide)

Snippet

Sponsor: Venkatesh Sampath | Conditions: Bronchopulmonary Dysplasia | Phase 1 | Status: RECRUITING